Skip to main content

When GBM Entered Our Lives

When Christina was diagnosed with Glioblastoma (GBM) in February 2020, our world flipped upside down. The idea of losing my wife to cancer became a terrifying reality. Emotions were chaotic, and thinking clearly felt impossible.

Our first instinct was to learn everything we could about this disease. Information came at us fast and from every direction. The most shocking fact? GBM is the most common primary malignant brain tumor in adults, with a median survival of only 15 months (1).

Treatment usually begins with a biopsy and tumor removal, followed by radiotherapy and chemotherapy with alkylating agents. Christina received temozolomide (TMZ), and later bevacizumab, a monoclonal antibody that blocks the tumor’s blood supply (10).

I’ve decided to write a series of posts documenting what I’ve learned about GBM and my ideas—naïve though they may be—about how we might improve outcomes for patients, from the perspective of a chemist.

During my chemistry career (1984–1998), I worked on synthesizing diagnostic reagents and anti-cancer drugs. I thought that knowledge might allow me to help Christina—and, in my hope, even save her.

Even though the current standard of care is limited, I believe there is still much that science can do for people facing this disease.

Understanding MGMT

When DNA in a cell is damaged, repair mechanisms kick in to maintain genetic integrity. Damage can come from the environment—or even from the normal process of DNA replication. Most errors are corrected, but some slip through. Some mutations drive evolution; others lead to cancer.

Why MGMT Matters

Alkylating chemotherapy targets DNA by adding methyl groups to guanine at the oxygen-6 position. MGMT (methylguanine-DNA methyltransferase) is an enzyme that repairs this damage. By removing the methyl group, MGMT allows cancer cells to survive chemotherapy.

In GBM, knowing whether MGMT is active is critical. Tumors lacking this enzyme respond better to alkylating agents like TMZ. Doctors measure this as MGMT promoter methylation: if the promoter is methylated, the gene is silenced, and the tumor is more likely to respond to treatment (2).

Christina’s tumor tested MGMT-methylated, predicting a good response to TMZ (9). For tumors without this methylation, chemotherapy may be less effective, and the benefits must be weighed against toxicity.

How TMZ Works (Simplified)

  • Goal: Damage tumor DNA so the cancer cell cannot replicate.

  • Challenge: MGMT may repair the damage, making chemotherapy less effective.

  • Predictive test: MGMT promoter methylation tells doctors whether TMZ is likely to work.

By understanding MGMT, researchers can personalize treatment and improve the chances of success, even if only slightly.

Could I Have Done More?

The hard truth is that, for Christina, there was nothing more I could have done. But I refuse to believe the fight is over for others.

In future posts, I want to explore MGMT inhibitors (4), what we know about them, and some ideas that might make current treatments more effective. Could we intervene earlier—targeting the MGMT promoter rather than the enzyme itself? Perhaps that’s part of what alkylating agents are already doing.

This journey is both personal and scientific. I will continue to research, reflect, and share, because I refuse to accept that this is the end for people like Christina.

References:

  1. Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
  2. Methylguanine-DNA methyltransferase (MGMT)
  3. Temozolomide Approval
  4. MGMT Inhibitors
  5. Chemotherapeutic Approaches for Targeting Cell Death Pathways
  6. Difference Between Necrosis and Apoptosis
  7. DNA Damage & Repair: Mechanisms for Maintaining DNA Integrity
  8. The Structure of DNA
  9. Methylguanine Methyltransferase Testing in Glioblastoma: When and How?
  10. How Bevacizumab works as Anti-angiogenic therapy
  11. Genes And Chromosones
  12. Promoter

Labels:

Comments

Post a Comment

Popular posts from this blog

The Planner 00Iren

When I tell my daughters that their mother was amazing, I am not sure they grasp the magnitude of her stature. They tell me, “Yes dad, we know,” but I want them to understand the steel in her soul. I remember the day I saw Christina for the first time. it was in the halls of the chemistry department at Simon Fraser University. We both entered a long hallway at the same time, walking in opposite directions in our white lab coats. We had the opportunity to take a good look at each other. When we passed, our eyes crossed. She kept walking without turning, but I looked back to see her disappear into one of the laboratories. I thought, “Wow, I do not have a remote chance with that girl!” Years later, after we reunited in Vancouver, she told me she had thought the same: "He is going to make a woman very happy one day." She said she had no idea it was going to be her. In 1993, after I received an ultimatum letter from Canada Immigration, I was left with no option but to escape to th...
3 comments
Read more

Our Charlie, Hegel

It was 1981, and I had barely survived my first year at the University of Havana, where I was studying chemistry. The leap from high school to university had been a huge adjustment—not just for me, but for many others. In the fall of 1979, about 250 of us began the program together. By the second year, fewer than 50 remained. That year we were introduced to a new subject: Philosophy. Every subject has to start somewhere, and we began with the classics—their ideas, their conflicts, their strengths and weaknesses. But one question weighed heavily on us: why study philosophy at all? Shouldn’t we be focused on chemistry—the nature of substances, their reactions, the concepts of atoms, molecules, and bonds? That was the very first challenge we posed to our philosophy lecturer, and to us, it seemed perfectly legitimate. The answer, fittingly, was philosophical. In the Soviet context, philosophy was meant to train us in analytical reasoning and critical thinking—by grappling with big questi...
Post a Comment
Read more

My Gift

  To my daughters, I tried to be her, and I could not. I tried to be their buddy, and I could not. Then I understood: I am Dad. That is my role, my strength, and my gift. Now, it is recorded forever, here.
Post a Comment
Read more